Welcome to our dedicated page for Molina Hlthcare SEC filings (Ticker: MOH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Molina Healthcare, Inc. filings document the regulatory record for a managed healthcare company serving Medicaid, Medicare and state insurance marketplace programs. Its 8-K reports disclose operating results, premium revenue and earnings guidance, Regulation FD investor presentations, material agreements, direct financial obligations, impairment charges and senior unsecured note financing.
The company's proxy and governance filings cover annual meeting proposals, director and executive compensation matters, equity incentive plan authorization and amendments to charter or bylaw provisions such as stockholder special-meeting rights. The filing record also describes capital-structure terms, credit agreement covenants, risk-factor references and shareholder voting outcomes.
Molina Healthcare Inc reports that Vanguard Capital Management beneficially owns 2,704,951 shares of Common Stock as of 03/31/2026. That stake represents 5.19% of the class; Vanguard reports sole voting power for 394,721 shares and sole dispositive power for 2,704,951 shares. The filing notes that dispositive and voting power is exercised by Vanguard Capital Management LLC and affiliated Vanguard business divisions.
Vanguard Portfolio Management reports beneficial ownership of 2,801,121 shares of Molina Healthcare Inc. Common Stock, representing 5.37% of the class as of 03/31/2026. The filing attributes sole dispositive power over 2,801,121 shares and sole voting power over 10,150 shares.
The filing states holdings include securities held by Vanguard funds and accounts over which Vanguard Portfolio Management LLC and listed affiliates exercise dispositive power. Ownership is reported on Schedule 13G and the signature is dated 04/29/2026.
Molina Healthcare reported first quarter 2026 results with GAAP diluted EPS of $0.27 and adjusted diluted EPS of $2.35, both sharply below the prior year. Total revenue was $10.8 billion, with premium revenue of about $10.2 billion, down 4% year over year.
Results were heavily affected by a $93 million impairment tied to the planned 2027 exit of the Medicare Advantage-Part D product, driving GAAP net income down to $14 million from $298 million. The consolidated medical care ratio rose to 91.1%, while the G&A ratio increased to 7.2%.
The company served roughly 5.0 million members as of March 31, 2026 and generated operating cash flow of $1,082 million versus $190 million a year earlier. Management reaffirmed 2026 guidance for premium revenue of about $42 billion, GAAP EPS of at least $1.90, and adjusted EPS of at least $5.00.
BlackRock, Inc. filed Amendment No. 13 to a Schedule 13G/A reporting beneficial ownership of 6,116,371 shares of Molina Healthcare Inc common stock, equal to 11.7% of the class as of 03/31/2026. The filing attributes sole voting power over 5,949,590 shares and sole dispositive power over 6,116,371 shares and notes holdings reflect aggregated Reporting Business Units rather than all BlackRock business units. The filing also identifies iShares Core S&P Small-Cap ETF as a holder with an interest exceeding 5%.
GROHOWSKI LEO P reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Leo P. Grohowski received a grant of 405 shares of common stock on April 1, 2026. The award was made under Molina Healthcare’s 2025 Equity Incentive Plan as part of his compensation for board service.
The filing states that directors receive an annual equity award valued at $220,000, with one quarter, or $55,000, granted on the first day of each quarter based on the closing share price. The closing price on April 1, 2026 was $135.82, resulting in the 405-share grant. Following this award, Grohowski directly holds 1,305 shares of Molina Healthcare common stock.
Lockhart Stephen H reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare, Inc. director Stephen H. Lockhart received a grant of 405 shares of common stock on April 1, 2026 under the company’s 2025 Equity Incentive Plan. The grant was valued at $55,000 based on a closing share price of $135.82, bringing his direct holdings to 4,147 shares.
This award represents one quarter of an annual equity grant of $220,000 provided to each director, with similar grants scheduled on the first day of each quarter using that day’s closing stock price.
ORLANDO STEVEN J reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Steven J. Orlando, through the Orlando Family Trust, received a grant of 405 shares of common stock on April 1, 2026. The shares were awarded under Molina’s 2025 Equity Incentive Plan as part of his director compensation, based on the closing price of $135.82 per share that day, equating to a quarterly equity value of $55,000 toward an annual equity award of $220,000. After this grant, the Orlando Family Trust holds 17,730 shares of Molina common stock, and an additional 1,500 shares are held indirectly in the reporting person’s 401(k) plan.
WOLF DALE B reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Dale B. Wolf received a grant of 405 shares of common stock on April 1, 2026 under the company’s 2025 Equity Incentive Plan, in connection with his board service. The award represents one quarterly installment of a $220,000 annual equity award, with this quarter’s $55,000 portion calculated using the April 1 closing price of $135.82 per share. Following this grant, indirect holdings for Wolf’s revocable trust increased to 15,396 shares of Molina Healthcare common stock.
ZORETIC RICHARD C reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Richard C. Zoretic received an equity grant of 405 shares of common stock on April 1, 2026, held by the Richard Charles Zoretic Revocable Living Trust. The grant was made under the company’s 2025 Equity Incentive Plan as part of his director compensation.
The shares were valued using the closing price of $135.82 on April 1, 2026, equating to a quarterly equity award of $55,000 and an annual equity award target of $220,000. Following this grant, the trust holds a total of 9,152 Molina Healthcare shares.